Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    - Added Revision: v3.4.3 - Deleted Revision: v3.4.2
    Difference
    0.0%
    Check dated 2026-03-07T06:29:16.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays 'Revision: v3.4.2' and no longer shows 'Revision: v3.4.1'.
    Difference
    0.0%
    Check dated 2026-02-13T13:32:25.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Plain Language Summary has been added to the Study Details page, and the record shows a new revision (v3.4.1). The previous revision (v3.4.0) was removed and new date entries for 2026-02-05, 2026-01-15, and 2025-12 were added.
    Difference
    0.1%
    Check dated 2026-02-06T09:26:47.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added UI controls to show/hide the glossary and updated metadata sections to include Last Update Submitted that Met QC Criteria and Last Update Posted, plus No FEAR Act Data with Revision: v3.4.0. Removed the older labels and the previous revision v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-22T17:43:55.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision 3.3.4 was added and Revision 3.3.3 was removed. This change affects only the revision history and does not alter core study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-01-15T10:50:44.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added an extensive list of Locations across multiple countries and regions. This expands where patients can participate in the trial.
    Difference
    3%
    Check dated 2025-12-17T20:26:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.